These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12417434)

  • 1. Astrocyte-induced T cell elimination is CD95 ligand dependent.
    Bechmann I; Steiner B; Gimsa U; Mor G; Wolf S; Beyer M; Nitsch R; Zipp F
    J Neuroimmunol; 2002 Nov; 132(1-2):60-5. PubMed ID: 12417434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L.
    Aragane Y; Kulms D; Metze D; Wilkes G; Pöppelmann B; Luger TA; Schwarz T
    J Cell Biol; 1998 Jan; 140(1):171-82. PubMed ID: 9425165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system.
    Cabaner C; Gajate C; Macho A; Muñoz E; Modolell M; Mollinedo F
    Br J Pharmacol; 1999 Jun; 127(4):813-25. PubMed ID: 10433487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons.
    Martin-Villalba A; Herr I; Jeremias I; Hahne M; Brandt R; Vogel J; Schenkel J; Herdegen T; Debatin KM
    J Neurosci; 1999 May; 19(10):3809-17. PubMed ID: 10234013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of neuronal density and subfield sizes in the hippocampus of CD95L-deficient (gld), CD95-deficient (lpr) and nondeficient mice.
    Kovac AD; Grammig J; Mahlo J; Steiner B; Roth K; Nitsch R; Bechmann I
    Eur J Neurosci; 2002 Jul; 16(1):159-63. PubMed ID: 12153542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloantigen-driven T cell death mediated by Fas ligand and tumor necrosis factor-alpha is not essential for the induction of allograft acceptance.
    Wagener ME; Konieczny BT; Dai Z; Ring GH; Lakkis FG
    Transplantation; 2000 Jun; 69(11):2428-32. PubMed ID: 10868653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
    Hahne M; Rimoldi D; Schröter M; Romero P; Schreier M; French LE; Schneider P; Bornand T; Fontana A; Lienard D; Cerottini J; Tschopp J
    Science; 1996 Nov; 274(5291):1363-6. PubMed ID: 8910274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for multiple CD95-CD95 ligand interactions in anteriorchamber-associated immune deviation induced by soluble protein antigen.
    Kezuka T; Streilein JW
    Immunology; 2000 Mar; 99(3):451-7. PubMed ID: 10712676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas receptor (CD95)-mediated apoptosis in leukemic cells.
    Komada Y; Sakurai M
    Leuk Lymphoma; 1997 Mar; 25(1-2):9-21. PubMed ID: 9130610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis.
    Schmidt M; Lügering N; Lügering A; Pauels HG; Schulze-Osthoff K; Domschke W; Kucharzik T
    J Immunol; 2001 Jan; 166(2):1344-51. PubMed ID: 11145719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
    Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
    J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95-driven apoptosis.
    Falsig J; Latta M; Leist M
    J Neurochem; 2004 Jan; 88(1):181-93. PubMed ID: 14675162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.
    Matsue H; Edelbaum D; Hartmann AC; Morita A; Bergstresser PR; Yagita H; Okumura K; Takashima A
    J Immunol; 1999 May; 162(9):5287-98. PubMed ID: 10228004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity in the Grid2Lc/+ mouse model of cerebellar neurodegeneration: glial CD95/CD95L plays a non-apoptotic role in persistent neuron loss-associated inflammatory reactions in the cerebellum.
    Vernet-der Garabedian B; Derer P; Bailly Y; Mariani J
    J Neuroinflammation; 2013 May; 10():65. PubMed ID: 23672668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
    Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
    Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis in mature T cells by tumour necrosis factor.
    Zheng L; Fisher G; Miller RE; Peschon J; Lynch DH; Lenardo MJ
    Nature; 1995 Sep; 377(6547):348-51. PubMed ID: 7566090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD95(APO-1/Fas)/CD95L system.
    Krammer PH
    Toxicol Lett; 1998 Dec; 102-103():131-7. PubMed ID: 10022244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation.
    Lu L; Qian S; Hershberger PA; Rudert WA; Lynch DH; Thomson AW
    J Immunol; 1997 Jun; 158(12):5676-84. PubMed ID: 9190916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.